Subcellular distribution of Ro ribonucleoprotein complexes and their constituents

Transcription

1 Journal of Cell Science 106, (1993) Printed in Great Britain The Company of Biologists Limited Subcellular distribution of Ro ribonucleoprotein complexes and their constituents Ron Peek*, Ger J. M. Pruijn, Annemiete J. W. van der Kemp and Walther J. van Venrooij Department of Biochemistry, University of Nijmegen, PO Box 9101, 6500 HB Nijmegen, The Netherlands *Author for correspondence SUMMARY Ro ribonucleoprotein particles (Ro RNPs) are complexes of several proteins with a small RNA polymerase III-transcribed Ro RNA. Despite their relative abundance and evolutionary conservation no function has as yet been ascribed to these complexes. Also their subcellular distribution is still largely unknown as immunofluorescence studies concerning their localization have produced conflicting data. We have used cell enucleation to fractionate cells into cytoplasmic and nuclear fractions. Analysis of these fractions revealed an exclusively cytoplasmic localization for the Ro RNPs. The majority of the Ro RNAs are shown to be stably associated with all three known Ro RNP proteins. Although no Ro RNAs could be detected in the nuclear fraction, the Ro RNP-specific proteins were abundantly present. These nuclear non-ro RNA-associated proteins are shown to be capable of binding Ro RNAs. Key words: enucleation, localization, Ro proteins, Ro RNP INTRODUCTION Autoantibodies directed against the Ro/SS-A and the La/SS-B antigens are commonly found in sera of patients suffering from systemic lupus erythematosus (SLE) or from Sjögren s syndrome. They have proven to be useful diagnostic markers of the disease and effective tools in the analysis of the antigens and the dissection of the complexes in which these antigens are present. In most human cell types studied so far the Ro ribonucleoprotein particles (RNPs) contain at least three proteins: the La protein, which is involved in the correct termination of RNA polymerase III transcription (Gottlieb and Steitz, 1989a,b), and the Ro RNP-specific proteins of 52 kda (Ro52) and 60 kda (Ro60) (Wolin and Steitz, 1984; Ben-Chetrit et al., 1988). In several hemopoietic cell types a different set of Ro proteins was detected. Red blood cells contain a 60 kda and a 54 kda protein, which are antigenically distinct from Ro60 and Ro52, respectively (Rader et al., 1989; Itoh et al., 1990). More recently, a novel 52 kda Ro protein was detected in human platelets, which further increases the heterogeneity found in human Ro RNP complexes (Itoh and Reichlin, 1991). Calreticulin, formerly described as a Ro RNA-associated protein (Lieu et al., 1988; McCauliffe et al., 1990), was shown recently not to be a Ro auto antigen (Rokeach et al., 1991; Pruijn et al., 1992). Besides the proteins mentioned above, Ro RNPs may contain additional components, as the presence of single copies of the Ro proteins, together with the La protein and one RNA molecule, cannot account for the molecular masses of 230 to 350 kda of Ro RNPs observed in gel filtration (Boire and Craft, 1990). The RNA component of Ro RNPs in human cells consists of one out of four different small ( nucleotides) polymerase III-transcribed RNAs called hy1, hy3, hy4 and hy5 RNA (hy2 is a degradation product of hy1). The distribution of these Y RNAs was also found to be heterogeneous. While nucleated human cells contain all four hy RNAs, albeit in different ratios (Pruijn et al., unpublished), red blood cells contain only hy1 and hy4 (O Brien and Harley, 1990), while in platelets only hy3 and hy4 could be detected (Itoh and Reichlin, 1991). In other species the number of Y RNAs varies from 4 (e.g. bovine) to only 2 (e.g. mouse and duck) (reviewed in Slobbe et al., 1991a). The predicted secondary structure of the hy RNAs shows extensive base pairing between the highly conserved 5 and 3 ends. The Ro60 protein binds to the terminal part of this stem structure (Wolin and Steitz, 1984; Pruijn et al., 1991), while the 52 kda Ro protein does not bind directly to the RNA but most likely associates to the particle via proteinprotein interactions with Ro60 (Slobbe et al., 1992). Unlike most RNA polymerase III transcripts the Y RNAs are not subjected to post-transcriptional modification at their 3 terminus (Wolin and Steitz, 1983), hence the La protein is thought to be a stable component of the Ro RNPs. In addition, the hy5 RNP appears to contain an additional unique antigenic determinant, which is absent in other Ro RNP particles (Boire and Craft, 1989). Although the intermolecular interactions in the Ro RNPs

2 930 R. Peek and others have been studied in some detail now (Slobbe et al., 1992; Pruijn et al., 1991), the subcellular distribution of these particles is still controversial. Ro RNPs have been localized in the nucleus as well as in the cytoplasm (Clark et al., 1969; Gaither et al., 1987). Studies using anti-ro antibodies in immunofluorescence report both nuclear and cytoplasmic staining (Ben-Chetrit et al., 1988; Slobbe et al., 1991b) while others show only nuclear staining (Harmon et al., 1984; Lopez-Robles et al., 1986), or a predominantly cytoplasmic localization (Alspaugh and Maddison, 1979; Hendrick et al., 1981; Bachmann et al., 1986). To unambiguously establish the subcellular distribution of the Ro RNPs and their constituents at the molecular level, we have fractionated human Jurkat and mouse 3T3 cells into a cytoplasmic and a nuclear fraction, and analyzed these fractions separately. To avoid nuclear leakage, which is known to occur during mechanical fractionation, we have used the cell enucleation procedure described by Zieve et al. (1988). The data presented in this paper indicate that the La protein and the Ro proteins are present in both the cytoplasm and the nucleus, while the Y RNAs are exclusively cytoplasmic. Furthermore, we show that the majority of the human Y RNAs are stably associated with Ro60 and Ro52 as well as with the La protein. In the nucleus Ro60 and Ro52 are not associated with Y RNA. These results suggest a model for the assembly of Ro RNPs and strongly imply a cytoplasmic function for these complexes. MATERIALS AND METHODS Cell culture Mouse 3T3 cells and human Jurkat, HeLa and HEp-2 cells were cultured in DMEM supplemented with 10% (v/v) fetal calf serum. Jurkat cells were maintained at a density of about cells per ml, while the other cell types were grown in monolayer cultures to about 80% confluency before use. Immunofluorescence Prior to immunofluorescence, cells were fixed in (i) methanol ( 20 C) for 5 minutes followed by rinsing with acetone or (ii) 3% paraformaldehyde in phosphate buffered saline (PBS) for 20 minutes at RT followed by a 5 minute incubation in 0.2% Triton X- 100 in PBS. After washing in PBS, fixed cells were incubated with affinity-purified antibodies for 30 minutes, then washed with PBS and incubated with FITC-labeled rabbit anti-human IgG (Dako, F123) for 30 minutes. Finally cells were washed and photographed under fluorescent illumination. Cell enucleation Human Jurkat and mouse 3T3 cells were fractionated into cytoplasmic and nuclear fractions using the enucleation method essentially as described by Zieve et al. (1988). Briefly, about cells were treated with cytochalasin B (10 µg/ml) for 10 minutes before enucleation. Cells were then concentrated into 3 ml of 12.5% Ficoll in DMEM and layered on a Ficoll step gradient in DMEM. After centrifugation at 37 C for 90 minutes at 130,000 g (SW40 rotor) cytoplasmic and nuclear fractions were collected. The nuclear contamination of the cytoplasmic fraction was tested by Hoechst (33258) staining. Cellular fractions were resuspended in 400 µl of PBS and sonicated 4 times for 15 seconds each. Debris was removed by centrifugation at 14,000 g for 5 minutes. RNA precipitation Protein A-agarose beads were coated with the appropriate antibodies by rotation for at least 1 hour in 500 µl IPP 500 (10 mm Tris-HCl, ph 8.0, 0.5 M NaCl, 0.1% Tween-20, 0.1% NP40) followed by washing twice with IPP 500 and once with IPP 150 (10 mm Tris-Cl, ph 8.0, 0.15 M NaCl, 0.1% Tween-20, 0.1% NP40). The coated beads were rotated with the cellular extract in 500 µl IPP 150 for 1 hour at RT. Precipitated RNA was isolated by washing 3 times with 1 ml of IPP 150 after which the beads were resuspended in 400 µl of IPP 150 containing 0.5% SDS and phenol/chloroform extracted. After ethanol precipitation the RNA was dissolved in 10 µl of sample buffer (80% formamide/1 mm EDTA/0.025% bromophenol blue) and loaded on a 10% polyacrylamide-8 M urea gel. Northern blot analysis RNA was size-fractionated on 10% polyacrylamide-urea gels and transferred to Hybond N + filters by electroblotting at 3 V/cm in M phosphate (ph 6.5) for 2 hours. Filters were air dried and baked for 2 hours at 80 C. Hybridizations were performed overnight at 65 C in 6 SSC/5 Denhardt s solution/100 µg/ml denatured herring sperm DNA. Labeled anti-sense hy RNA transcripts or random primed (Feinberg and Vogelstein, 1983) hy or U1 DNA fragments were used as probes. Following hybridization filters were washed twice at 65 C in 0.2 SSC. Filters were exposed to X-ray film at 70 C overnight. Antisera Antibodies against either Ro60, Ro52 or the La protein were isolated from patient sera by affinity column chromatography using the respective recombinant proteins (Slobbe et al., 1992) coupled to CNBr-activated Sepharose 4B as antigens. Eluted antibodies were checked for reactivity and specificity by western blot analysis and precipitation of in vitro translated [ 35 S]methionine-labeled Ro60, Ro52 and La proteins. Affinity-purified antibody preparations did not show any cross-reactivities. Western blot analysis Cytoplasmic and nuclear enucleation extracts were run on standard 10% SDS-PAGE gels and blotted to nitrocellulose. After blocking with PT (PBS/0.5% Tween-20) containing 3% BSA for 1 hour, blots were incubated with diluted sera in PT-1% BSA for 2 hours. Filters were washed 3 times with PT and incubated with 125 I-Protein A (1 µci/100 ml) in PT-1% BSA for 1 hour. After washing for 30 minutes in PT and for 30 minutes in water the blots were exposed to X-ray film at 70 C. The relative amount of Ro and La protein was estimated by densitometric scanning. Reconstitution assay Reconstitution of 32 P-labeled Y RNA-protein complexes was performed as described (Slobbe et al., 1992), using equivalent amounts of cytoplasmic or nuclear extract. RESULTS Localization of Ro60 and La proteins by immunofluorescence In view of the controversial data described in previous studies, the subcellular distribution of the Ro antigen detected by immunofluorescence was likely to depend on the fixation method used. We therefore applied two different commonly used fixation methods (methanol/acetone and paraformaldehyde) on HEp-2 and HeLa cells prior to

3 Subcellular distribution of Ro RNPs 931 Fig. 1. Localization of Ro60 and La protein by immunofluoresence. Indirect immunofluorescent patterns of HEp-2 cells (A,C,E and G) and HeLa cells (B,D,F and H) fixed with methanol (A,B,E and F) or paraformaldehyde (C,D,G and H) and incubated with affinitypurified monospecific human anti-ro60 antibodies (A-D) or monospecific human anti-la antibodies (E-H). immunofluorescence microscopy. Differences both in intensity and in localization of Ro60 and La fluorescence signals could be observed. After methanol/acetone fixation affinity-purified, monospecific antibodies directed against Ro60 gave a speckled nuclear and relatively strong cytoplasmic staining (Fig. 1A,B), while the fixation with paraformaldehyde gave a much brighter, diffuse nuclear fluorescence and hardly any cytoplasmic staining (Fig. 1C,D). Apart from the cytoplasmic staining essentially the same patterns were observed using monospecific antibodies against the La protein (Fig. 1E-H). Obviously, a precise determination of the localization of Ro60 and La proteins is not feasible using immunofluorescence. Localization of Ro RNPs As an alternative procedure to determine the subcellular localization of the Ro RNPs, human Jurkat cells and mouse 3T3 fibroblasts were separated into a nuclear and a cytoplasmic fraction using cell enucleation. This technique has previously been shown to give a reliable separation of cytoplasmic and nuclear material (Zieve et al., 1988). The efficiency of the enucleation was monitored by staining part of the resulting fractions with Hoechst (33258) reagent, which specifically stains the nuclei. While the nuclear contamination of the cytoplasmic fraction was usually between 5 and 10% for the human cells, the mouse 3T3 cytoplasmic fraction contained hardly any nuclear material (data not shown). Extracts of the enucleation fractions were used to determine the distribution of the Y RNAs and their asssociation with proteins. The Ro RNP-specific Y RNAs appeared to be exclusively present in the cytoplasmic fraction of enucleated Jurkat and 3T3 cells (Fig. 2A). Despite the only slight contamination of the cytoplasmic fraction with nuclear material, hybridization with an U1 snrna- (Fig. 2A) or U5 snrna- (not shown) specific probe, which A B Fig. 2. Northern blot analysis of Jurkat and 3T3 cell enucleation fractions. (A) RNA isolated from cytoplasmic (C) and nuclear (N) enucleation fractions of human Jurkat and mouse 3T3 cells was size-fractionated on a polyacrylamide-urea gel, blotted and hybridized with probes for U1 and Y RNAs. As a control for hybridization a lane containing 5 µg of total HeLa cell RNA was included. (B) Jurkat cytoplasmic and nuclear enucleation fractions were immunoprecipitated with monospecific anti-la (αla) or anti-ro60 (αro60) antibodies. RNA isolated from precipitated complexes and from the post-immunoprecipitate supernatant (P.I.) was northern blotted and hybridized with probes for U1, hy1 and hy5 RNA.

4 932 R. Peek and others were used as controls, revealed an unexpected, approximately equal distribution of U snrna between the cytoplasm and the nucleus of Jurkat cells. A similar distribution of U1 snrna was observed after enucleation of other human cells, such as Molt-4, CEM, HL-60, K-562 and U937, the fibroblast cell line HF-V32 and primary human fibroblasts (data not shown). In contrast to the human cells, the enucleation fractions of the mouse 3T3 cells showed the expected distribution of U1 snrna; i.e. the bulk being in the nuclear fraction. Immunoprecipitation using monospecific anti-la or anti- Ro60 antibodies revealed that the Y RNAs are not only associated with Ro60, but these RNAs could also be efficiently precipitated using antibodies against the La protein (Fig. 2B). Similar results were obtained for hy3 and hy4 RNA, although the level of association of these RNAs with the La protein showed some variation between experiments (not shown). The cytoplasmic localization of the Ro RNPs was probably not due to the treatment of the cells with cytochalasin B prior to the enucleation procedure, as the immunofluorescence of 3T3 cells using anti-ro60 or anti-la antibodies showed no marked changes in the distribution of Ro60 or the La protein after incubation with this drug (not shown). From the experiments described above we conclude that the Ro RNPs are located predominantly in the cytoplasm. Association of hy RNAs with the La and Ro proteins The Y RNAs are not processed at their 3 termini and therefore retain the oligouridylate stretch representing the major La protein binding site. Most if not all of the Y RNAs from Jurkat cells indeed seem to be associated not only with Ro60, but also with the La protein (Fig. 2B). To determine whether the Y RNAs were quantitatively associated with these proteins in human cells, total HeLa cell S100 extract was subjected to several consecutive immunoprecipitations using monospecific antibodies directed against either the La or Ro proteins. Northern blot analysis of the RNA isolated from the immunoprecipitates revealed that the Y RNAs could be efficiently depleted from the extract using either anti-ro60 or anti-la antibodies, as illustrated by the absence of hy1 and hy5 RNA in the final post-immunoprecipitate supernatants (Fig. 3, top and middle). Four subsequent immunoprecipitations with monospecific anti-ro52 antibodies also removed most of the Y RNA from the extract, leaving only a small portion in the supernatant (Fig. 3, bottom). Hybridization with a U1 snrna-specific probe confirmed the specificity of these precipitations and indicated that the RNA isolated from the final post-immunoprecipitate was intact. These data strongly suggest that the majority of the Y RNAs are associated with Ro52, while almost all Y RNAs are associated with Ro60 and the La protein. Fig. 3. The human Y RNAs are associated with both the La and Ro proteins. HeLa S100 extract was immunodepleted by four consecutive immunoprecipitations (1,2,3,4) using monospecific anti-la antibody (top), anti-ro60 antibody (middle) or anti-ro52 antibody (bottom). RNA isolated from the input (10% of the total), the immunoprecipitated complexes and the final postimmunoprecipitate supernatant (P.I.; 10% and 50% of the total) was northern blotted and hybridized with probes for U1, hy1, and hy5 RNA. Localization of Ro RNP proteins As shown above the majority of the hy RNAs appear to be present in the cytoplasm being associated with the La and the Ro proteins. Paradoxically, the studies using immunofluorescence for the detection of the Ro RNP-associated proteins suggest a primarily nuclear localization (Fig. 1A-D). Since the import of Ro RNP proteins into the nucleus during fixation of the cells seems very unlikely it was investigated whether all Ro60 was complexed with the Y RNAs or whether free (i.e. non-y RNA-bound) Ro60 exists within the cell nucleus. This could explain the discrepancy between the nuclear localization observed using immunofluorescence and the cytoplasmic localization of the Ro RNPs obtained by the cell fractionation. To this end western blots of nuclear and cytoplasmic enucleation fractions of 3T3 and Jurkat cells were probed with affinitypurified antibody directed against the La, the Ro60 or Ro52 proteins. The results revealed that free Ro proteins are indeed present within the cell nucleus and represent about one third of the total amount in Jurkat cells, while in mouse 3T3 cells the distribution of Ro60 between cytoplasm and nucleus is about equal. For the La protein about one third of the total amount resides within the cell nucleus of both Jurkat and 3T3 cells (Fig. 4). In the enucleation fractions of mouse 3T3 cells the Ro52 protein was not detectable (not shown). The absence of Ro52 in rodent cells is in agreement with our previous results, which indicated that the Ro52 protein could only be detected by immunological techniques in cells of primate origin (Slobbe et al., 1991b). Free, non-y RNA-bound, Ro60 and Ro52 proteins could also be detected by a different approach. When a total Jurkat cell extract was depleted of Ro RNPs by several anti-la immunoprecipitations (removing all La protein) about 30%

5 Subcellular distribution of Ro RNPs 933 Fig. 4. Subcellular distribution of Ro52, Ro60 and La protein. Cytoplasmic and nuclear enucleation extracts of Jurkat and 3T3 cells were analyzed by western blotting and incubated with human sera containing antibodies against either Ro52, Ro60 or the La protein. Bound antibodies were detected using 125 I-Protein A. Note that the mouse La protein appears to be somewhat smaller than the human La protein. The Ro52 protein was not detectable in the 3T3 cell extracts (not shown) as published previously (Slobbe et al., 1991b). of Ro60 and 40% of Ro52 remained in the supernatant (Fig. 5). These results, together with the presence of free nuclear Ro protein indicate that a significant amount of Ro protein is not associated with Ro RNPs. To determine whether the non-y RNA-associated Ro60 was capable of binding Y RNA, total cellular extract of Jurkat cells was first depleted of all Ro RNPs by several immunoprecipitations using affinity-purified anti-la antibodies. As illustrated by the hybridization to hy1 and hy5 RNAs (Fig. 6A) the Y RNAs are indeed completely removed from the extract, while the U1 snrna, which is reported to be complexed with the La protein for only a small portion (Keene et al., 1987; see also Fig. 3), remains largely in the post-immunoprecipitate (P.I.) supernatant. To the depleted extract, containing no endogenous Y RNAs, in vitro-transcribed 32 P-labeled hy1 or hy5 was added. After incubation these RNAs could be efficiently precipitated using antibody against Ro60 (Fig. 6B), indicating that the Ro RNP-depleted total cellular extract still contained Ro60 able to bind Y RNAs. The enucleation fractions of the mouse 3T3 cells, which showed the expected distribution of the U1 snrna, were used to determine whether the free Ro60 was located in the cytoplasm, in the nucleus or in both compartments. To remove the Ro RNP-associated Ro60, the cytoplasmic extract was immunodepleted by anti-la precipitations as described before. In contrast to the human Jurkat and HeLa cells, the cytoplasmic fraction of the mouse 3T3 cells could not be completely depleted of Ro RNPs using anti-la immunoprecipitations. About 5% of the my1 RNA remained after anti-la-depletion, suggesting that in these cells a small portion of the Ro RNPs is not associated with the La protein (Fig. 6C). The addition of in vitro-transcribed 32 P-labeled hy1 RNA to a non-depleted 3T3 cytoplasmic extract, followed by immunoprecipitation with monospecific anti-ro60 antibodies, resulted in a very efficient precipitation of the labeled RNA (Fig. 6D, lane 1). The signal became much weaker (lane 2) when this extract was first largely depleted of Ro RNPs by anti-la immunodepletion, as shown in Fig. Fig. 5. Not all Ro60 and Ro52 is complexed in Ro RNPs. Total Jurkat cell extract was immunodepleted of all La protein and analyzed for the amount of La, Ro60 and Ro52 protein by western blotting using affinity-purified, monospecific antibodies. Monoclonal antibody against the human hnrnp A1 protein (courtesy of Prof. G. Dreyfuss) was included to correct for the amount of protein present in each lane. Bound antibodies were detected using 125 I-Protein A. The Ro60 signal in the La-depleted extract is weak and not easily seen here. 6C. Obviously, not much free Ro60 is available in the cytoplasm for binding labeled hy RNA. This indicates that the strong signal obtained in lane 1 derives mainly from Ro RNP-associated Ro60 molecules, exchanging from an endogenous non-labeled Y RNA to the added labeled hy1 RNA. A further treatment of the La-depleted extract by an anti-ro60 precipitation prior to the addition of 32 P-labeled hy1 RNA diminished the signal to background levels (lane 3). When labeled hy1 RNA was added to 3T3 nuclear extracts, the signal was stronger (lane 4) than the signal obtained with the La-depleted cytoplasmic extract (lane 2). If we assume that the signal obtained with the not completely Ro RNP-depleted cytoplasmic extract (lane 2) results from an exchange of Ro60 from Ro RNPs that are not associated with the La protein (Fig. 6C), then the results presented above strongly suggest that the free Ro60 capable of Y RNA binding is largely, if not completely, located within the cell nucleus. Similar results were obtained using Jurkat cell enucleation fractions (not shown). DISCUSSION The localization of antigens using the immunofluorescence technique critically depends on the fixation method used. In this study fixation of cells following two commonly used procedures gave clear qualitative as well as quantitative differences when using antibodies against Ro60 and the La protein. The use of conventional mechanical cell fractionation in order to determine the subcellular localization of particular components is also prone to artifacts and leads to massive nuclear leakage (Zieve and Penman, 1976). Alternatively, it has been shown that cell enucleation of cytochalasin B-treated mouse L929 cells results in a reliable separation of cytoplasm and intact nuclei, showing the expected distribution of, for example, the U snrnas and their precursors (Zieve et al., 1988). The relatively short exposure of the intact cells to cytochalasin B during the enucleation procedure has also no detectable effects on dis-

6 934 R. Peek and others A B Fig. 6. The free Ro60 is capable of binding C D Y RNA. (A) Total Jurkat cell extract was immunodepleted with monospecific anti- La. For details, see legend to Fig. 3. (B) In vitro-transcribed 32 P-labeled hy1 and hy5 RNA was incubated in either anti-ladepleted total Jurkat cell extract (lanes 1 and 2, respectively) or in buffer only (lanes 3 and 4, respectively). After incubation Ro60 was immunoprecipitated using monospecific anti-ro60 antibodies and precipitated RNAs were analyzed on a 10% polyacrylamide-urea gel (top). As a control for possible RNA degradation during the incubation the postimmunoprecipitate supernatant was also analyzed (bottom). (C) Cytoplasmic extract of 3T3 cells was immunodepleted using monospecific anti-la antibodies. For details, see legend to Fig. 3. (D) In vitro 32 P-labeled hy1 RNA was immunoprecipitated with monospecific anti-ro60 antibodies after incubation in 3T3 cell cytoplasmic extract (lane 1), in anti-la-depleted cytoplasmic extract (lane 2), in anti-la-depleted and anti-ro60 treated cytoplasmic extract (lane 3) or in nuclear extract (lane 4). Precipitated RNA was analyzed on a 10% polyacrylamide-urea gel. tribution of La or Ro RNPs judged from the unchanged immunofluorescence patterns when using anti-la or anti- Ro60 antibodies. The mouse 3T3 cells used in our experiments showed the expected distribution of U1 snrna between nucleus and cytoplasm, indicating that these cells can be efficiently enucleated giving rise to a reliable cytoplasm-nucleus separation. Remarkably, the human cells used in this study, including several cell lines and primary cells, showed an approximately equal distribution of U1 and U5 (Jurkat) snrna between the cytoplasm and the nucleus, in spite of the minimal contamination of the cytoplasmic fraction with nuclei. Although we cannot completely exclude the possibility that nuclear leakage of (certain) RNPs does occur in human cells during fractionation we assume that the observed U snrna distribution is an accurate representation of the situation in these cells. The northern blot analysis of the human Jurkat and the mouse 3T3 enucleation fractions showed that the Y RNAs are located exclusively in the cytoplasm. The human Y RNAs were shown to be quantitatively associated with the Ro60 as well as the La protein. Furthermore, it is demonstrated that the human Y RNAs can be efficiently precipitated using affinity-purified antibodies directed against the Ro52 protein. Other studies describing the composition of the Ro RNPs report that the Y RNAs are only partially associated with the La protein (Mamula et al., 1989; Boire and Craft, 1990), while in human erythrocytes the Y RNAs could not be precipitated by anti-la sera at all (O Brien and Harley, 1990). It is possible that these discrepancies are due to the use of different cell types or culturing conditions or to the fine specificity of the antibodies used. In contrast to the predominantly nuclear localization of Ro60 revealed by immunofluorescence (see also Fig. 1), our enucleation studies indicate that about 50-70% of the Ro60 molecules are cytoplasmic and associated with Y RNAs. This discrepancy can be explained by assuming that most of the antigenic determinants of Ro60, associated with both Y RNA and Ro52, are not accessible after the fixation procedure. In contrast, the free, non-y RNA-bound Ro60 antigen in the nucleus might still be recognized sufficiently to produce an almost exclusive nuclear immunofluorescent staining. An alternative, but in our view less likely possibility is to assume selective leakage of Ro RNPs from the cytoplasm during fixation. Although the majority of Ro60 in the nucleus is not associated with Y RNA, reconstitution experiments showed that at least part of this Ro60 fraction is capable of binding Y RNA. The present data do not exclude the possibility that Ro60-Ro52 complexes exist in the nucleus. The relatively high percentage of nuclear, non-y RNA-associated Ro protein could be indicative for additional functions of these proteins besides their role in Ro RNPs. The presence of zinc finger-like structures, similar to those found in several DNA-binding proteins, in both Ro52 and Ro60 (Deutscher et al., 1988; Ben-Chetrit et al., 1989; Chan et al., 1991; Itoh et al., 1991), together with the high degree of homology between Ro52 and the mouse rpt-1 and the human ret transforming protein support this idea (Chan et al., 1991). The data presented above suggest the following model for the biosynthesis of Ro RNPs. The newly synthesized Ro proteins are, like the La protein, actively transported to the nucleus (Simons et al., unpublished) to a pool of free proteins. The newly synthesized Y RNAs, which become La-bound during transcription termination, are subsequently bound by Ro60 and Ro52. This Ro RNP complex is then rapidly and quantitatively transported from the nucleus to the cytoplasm. Although the function of Ro RNPs has not yet been determined, their cytoplasmic localization together with the high evolutionary conservation of both the Ro proteins and their cognate RNAs point to an important role in cytoplasmic processes. We thank Dr G. W. Zieve for helpful discussions. This investigation was carried out with financial aid from Het Nationaal Reumafonds of the Netherlands and was supported in part by the Netherlands Foundation for Chemical Research (SON) with finan-

7 Subcellular distribution of Ro RNPs 935 cial aid from the Netherlands Organization for Scientific Research (NWO). The research of Dr G. J. M. Pruijn has been made possible by a fellowship of the Royal Netherlands Academy of Arts and Sciences. REFERENCES Alspaugh, M. and Maddison, P. (1979). Resolution of the identity of certain antigen-antibody systems in systemic lupus erythematosus and Sjögrens syndrome: a laboratory collaboration. Arthritis Rheum. 22, Bachmann, M., Mayet, W. J., Schroeder, H. C., Pfeifer, K., Meyer zum Buschenfelde, K. H. and Mueller, W. E. G. (1986). Association of La and Ro antigens with intracellular structures in HEp-2 carcinoma cells. Proc. Nat. Acad. Sci. USA 83, Ben-Chetrit, E., Chan, E. K. L., Sullivan, K. F. and Tan, E. M. (1988). A 52 kd protein is a novel component of the SS-A/Ro antigenic particle. J. Exp. Med. 167, Ben-Chetrit, E., Gandy, B. J., Tan, E. M. and Sullivan, K. F. (1989). Isolation and characterization of a cdna clone encoding the 60 kd component of the human SS-A/Ro ribonucleoprotein autoantigen. J. Clin. Invest. 83, Boire, G. and Craft, J. (1989). Biochemical and immunological heterogeneity of the Ro ribonucleoprotein particles. Analysis with sera specific for the Ro hy5 particle. J. Clin. Invest. 84, Boire, G. and Craft, J. (1990). Human Ro ribonucleoprotein particles: characterization of native structure and stable association with the La polypeptide. J. Clin. Invest. 85, Chan, E. K. L., Hamel, J. D., Buyon, J. P. and Tan, E. M. (1991). Molecular definition and sequence motifs of the 52-kD component of human SS-A/Ro autoantigen. J. Clin. Invest. 87, Clark, G., Reichlin, M. and Tomasi, T. (1969). Characterization of a soluble cytoplasmic antigen reactive with sera from patients with systemic lupus erythematosus. J. Immunol. 102, Deutscher, S. L., Harley, J. B. and Keene, J. D. (1988). Molecular analysis of the 60 kd human Ro ribonucleoprotein. Proc. Nat. Acad. Sci. USA 85, Feinberg, A. P. and Vogelstein, B. (1983). A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 132, Gaither, K. K., Fox, O. R., Yamagata, H., Mamula, M. J., Reichlin, M. and Harley, J. B. (1987). Implications of anti-ro/sjögren syndrome A antigen autoantibody in normal sera for autoimmunity. J. Clin. Invest. 79, Gottlieb, E. and Steitz, J. A. (1989a). The RNA binding protein La influences both the accuracy and efficiency of RNA polymerase III transcription in vivo. EMBO J. 8, Gottlieb, E. and Steitz, J. A. (1989b). Function of the mammalian La protein: evidence for its activity in transcription termination by RNA polymerase III. EMBO J. 8, Harmon, C., Deng, J.-S., Peebles, C. and Tan, E. (1984). The importance of tissue substrate in the SS-A/Ro antigen-antibody system. Arthritis Rheum. 27, Hendrick, J. P., Wolin, S. L., Rinke, J., Lerner, M. R. and Steitz, J. A. (1981). Ro small cytoplasmic ribonucleoproteins are a subclass of La ribonucleoproteins: Further characterization of the Ro and La small ribonucleoproteins from uninfected and infected mammalian cells. Mol. Cell. Biol. 1, Itoh, K., Itoh, Y. and Frank, M. B. (1991). Protein heterogeneity in the human Ro (SS-A) ribonucleoproteins. The 52 kd and 60 kd Ro/SS-A autoantigens are encoded by separate genes. J. Clin. Invest. 87, Itoh, K., Kreit, J. D. and Reichlin, M. (1990). Organ distribution of the Ro (SS-A) antigen in the guinea pig. Arthritis Rheum. 33, Itoh, Y. and Reichlin, M. (1991). Ro/SSA antigen in human platelet: different distributions of the isoforms of Ro-SSA protein and the Ro/SSA-binding RNAs. Arthritis Rheum. 34, Keene, J. D., Deutscher, S. L., Kenan, D. and Kelekar, A. (1987). Nature of the La and Ro RNPs. Mol. Biol. Rep. 12, Lieu, T. S., Newkirk, M. M., Capra J. D. and Sontheimer, R. D. (1988). Molecular characterization of human Ro/SS-A antigen. Amino terminal sequence of the protein moiety of human Ro/SS-A antigen and immunological activity of a corresponding synthetic peptide. J. Clin. Invest. 82, Lopez-Robles, E., Herrera-Esparza, R. and Avalosdiaz, E. (1986). Cellular localization of the Ro/SS-A antigen. Clin. Rheum. 5, Mamula, M. J., Silverman, E. D., Laxer, R. M., Bentur, L., Isacovics, B. and Hardin, J. (1989). Human monoclonal anti-la antibodies. The La protein resides on a subset of Ro-particles. J. Immunol. 143, McCauliffe D. P., Lux, F. A., Lieu, T. S., Sanz, I., Hanke, J., Newkirk, M. M., Bachinski, L. L., Itoh, Y., Siciliano, M. J., Reichlin, M., Sontheimer, R. D. and Capra, J. D. (1990). Molecular cloning, expression and chromosome 19 localization of a human Ro/SS-A autoantigen. J. Clin. Invest. 85, O Brien, C. A. and Harley, J. B. (1990). A subset of hy RNAs is associated with erythrocyte Ro ribonucleoproteins. EMBO J. 9, Pruijn, G. J. M., Bozic, B., Schoute, F., Rokeach, L. A. and Van Venrooij, W. J. (1992). Refined definition of the 56K and other autoantigens in the kda region. Mol. Biol. Rep. 16, Pruijn, G. J. M., Slobbe, R. L. and Van Venrooij, J. W. (1991). Analysis of protein-rna interactions within Ro ribonucleoprotein complexes. Nucl. Acids Res. 19, Rader, M. D., O Brien, C. A., Yunshang, L., Harley, J. D. and Reichlin, M. (1989). Heterogeneity of the Ro/SS-A antigen. Different molecular forms in lymphocytes and red blood cells. J. Clin. Invest. 83, Rokeach, L. A., Haselby, J. A., Meilof, J. F., Smeenk, R. J. T., Unnasch, T. R., Greene, B. M. and Hoch S. O. (1991). Characterization of the human autoantigen calreticulin. J. Immunol. 147, Slobbe, R. L., Pruijn, G. J. M. and Van Venrooij, W. J. (1991a). Ro (SS- A) and La (SS-B) ribonucleoprotein complexes: structure, function and antigenicity. Ann. Med. Interne142, Slobbe, R. L., Pruijn, G. J. M., Damen, W. G. M., Van der Kemp, J. W. C. M. and Van Venrooij, W. J. (1991b). The detection and occurrence of the 60 and 52 kda Ro (SS-A) antigens and of autoantibodies against these proteins. Clin. Exp. Immunology86, Slobbe, R. L., Pluk, W., Van Venrooij, W. J. and Pruijn, G. J. M. (1992). Ro ribonucleoprotein assembly in vitro. J. Mol. Biol. 227, Wolin, S. L. and Steitz, J. A. (1983). Genes for two small cytoplasmic Ro RNAs are adjacent and appear to be single copy in the human genome. Cell 32, Wolin, S. L. and Steitz, J. A. (1984). The Ro small cytoplasmic ribonucleproteins: identification of the antigenic protein and its binding site on the Ro RNAs. Proc. Nat. Acad. Sci. USA 81, Zieve, G. W., Sauterer, R. A. and Feeney, R. J. (1988). Newly synthesized small nuclear RNAs appear transiently in the cytoplasm. J. Mol. Biol. 199, Zieve, G. W. and Penman, S. (1976). Small RNA species of HeLa cell: metabolism and subcellular localization. Cell 8, (Received 30 June Accepted 3 August 1993)